Antithrombin reduces reperfusion-induced hepatic metastasis of colon cancer cells

World Journal of Gastroenterology

Volumn 12, Issue 1, 2006, Pages 60-65

  Kurata, Masanao ^a   Okajima, Kenji ^b   Kawamoto, Toru ^a   Uchiba, Mitsuhiro ^c   Ohkohchi, Nobuhiro ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^c KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Antithrombin; E selectin; Hepatic ischemia reperfusion; Metastasis; Prostacyclin; Tumor necrosis factor

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; 9 DEOXY 9ALPHA,6 NITRILO 15 (4 PROPYLCYCLOHEXYL) 16,17,18,19,20 PENTANORPROSTAGLANDIN F1 ALPHA METHYL ESTER; ANTITHROMBIN; ARGATROBAN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INDOMETACIN; PROSTACYCLIN DERIVATIVE; THROMBIN INHIBITOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CLOTTING DISORDER; COLON CANCER; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG MECHANISM; HEPATIC ARTERY; LIVER ISCHEMIA; LIVER METASTASIS; LIVER RESECTION; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PORTAL VEIN; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY;

EID: 31144440675     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v12.i1.60     Document Type: Article

References (28)

1. Arnoletti JP, Brodsky J. Reduction of transfusion requirements during major hepatic resection for metastatic disease. Surgery 1999; 125: 166-171
2. Capussotti L, Massucco P, Ribero D, Vigano L, Muratore A, Calgaro M. Extended lymphadenectomy and vein resection for pancreatic head cancer: outcomes and implications for therapy. Arch Surg 2003; 138: 1316-1322
3. Ku Y, Kusunoki N, Shiotani M, Maeda I, Iwasaki T, Tominaga M, Kitagawa T, Fukumoto T, Suzuki Y, Kuroda Y. Stimulation of haematogenous liver metastases by ischaemia-reperfusion in rats. Eur J Surg 1999; 165: 801-807
4. Alexiou D, Karayiannakis AJ, Syrigos KN, Zbar A, Kremmyda A, Bramis I, Tsigris C. Serum levels of E-selectin, ICAM-1 and VCAM-1 in colorectal cancer patients: correlations with clinicopathological features, patient survival and tumour surgery. Eur J Cancer 2001; 37: 2392-2397
5. Ye C, Kiriyama K, Mistuoka C, Kannagi R, Ito K, Watanabe T, Kondo K, Akiyama S, Takagi H. Expression of E-selectin on endothelial cells of small veins in human colorectal cancer. Int J Cancer 1995; 61: 455-460
6. Uotani H, Yamashita I, Nagata T, Kishimoto H, Kashii Y, Tsukada K. Induction of E-selectin after partial hepatectomy promotes metastases to liver in mice. J Surg Res 2001; 96: 197-203
7. Wittig BM, Kaulen H, Thees R, Schmitt C, Knolle P, Stock J, Meyer zum Buschenfelde KH, Dippold W. Elevated serum E-selectin in patients with liver metastases of colorectal cancer. Eur J Cancer 1996; 32A: 1215-1218
8. Kitagawa T, Matsumoto K, Iriyama K. Serum cell adhesion molecules in patients with colorectal cancer. Surg Today 1998; 28: 262-267
9. Burke J, Zibari GB, Brown MF, Granger N, Kelly R, Singh I, McDonald JC. Hepatic ischemia-reperfusion injury causes E-selectin upregulation. Transplant Proc 1998; 30: 2321-2323
10. Colletti LM, Cortis A, Lukacs N, Kunkel SL, Green M, Strieter RM. Tumor necrosis factor up-regulates intercellular adhesion molecule 1, which is important in the neutrophil-dependent lung and liver injury associated with hepatic ischemia and reperfusion in the rat. Shock 1998; 10: 182-191
11. Rosenberg RD. Biochemistry of heparin antithrombin interactions, and the physiologic role of this natural anticoagulant mechanism. Am J Med 1989; 87: 2S-9S
12. Uchiba M, Okajima K, Murakami K, Okabe H, Takatsuki K. Attenuation of endotoxin-induced pulmonary vascular injury by antithrombin III. Am J Physiol 1996; 270: L921-L930
13. Oh-ishi S, Utsunomiya I, Yamamoto T, Komuro Y, Hara Y. Effects of prostaglandins and cyclic AMP on cytokine production in rat leukocytes. Eur J Pharmacol 1996; 300: 255-259
14. Ollivier V, Parry GC, Cobb RR, de Prost D, Mackman N. Elevated cyclic AMP inhibits NF-kappaB-mediated transcription in human monocytic cells and endothelial cells. J Biol Chem 1996; 271: 20828-20835
15. Harada N, Okajima K, Kushimoto S, Isobe H, Tanaka K. Antithrombin reduces ischemia/reperfusion injury of rat liver by increasing the hepatic level of prostacyclin. Blood 1999; 93: 157-164
16. Harada N, Okajima K, Uchiba M, Kushimoto S, Isobe H. Antithrombin reduces ischemia/reperfusion-induced liver injury in rats by activation of cyclooxygenase-1. Thromb Haemost 2004; 92: 550-558
17. Ishiguro K, Kojima T, Kadomatsu K, Nakayama Y, Takagi A, Suzuki M, Takeda N, Ito M, Yamamoto K, Matsushita T, Kusugami K, Muramatsu T, Saito H. Complete antithrombin deficiency in mice results in embryonic lethality. J Clin Invest 2000; 106: 873-878
18. Inoue Y, Kashima Y, Aizawa K, Hatakeyama K. A new rat colon cancer cell line metastasizes spontaneously: biologic characteristics and chemotherapeutic response. Jpn J Cancer Res 1991; 82: 90-97
19. Okuno K, Hirai N, Lee YS, Kawai I, Shigeoka H, Yasutomi M. Involvement of liver-associated immunity in hepatic metastasis formation. J Surg Res 1998; 75: 148-152
20. CLAUSSA. Rapid physiological coagulation method in determination of fibrinogen. Acta Haematol 1957; 17: 237-246
21. Ramos E, Closa D, Hotter G, Rosello-Catafau J, Gelpi E, Fernandez-Cruz L. The impact of arterialization on prostanoid generation after liver transplantation in the rat. Transplantation 1994; 58: 140-144
22. Brodt P, Fallavollita L, Bresalier RS, Meterissian S, Norton CR, Wolitzky BA. Liver endothelial E-selectin mediates carcinoma cell adhesion and promotes liver metastasis. Int J Cancer 1997; 71: 612-619
23. Okajima K, Harada N, Kushimoto S, Uchiba M. Role of microthrombus formation in the development of ischemia/reperfusion-induced liver injury in rats. Thromb Haemost 2002; 88: 473-480
24. Shankar R, de la Motte CA, Poptic EJ, DiCorleto PE. Thrombin receptor-activating peptides differentially stimulate platelet-derived growth factor production, monocytic cell adhesion, and E-selectin expression in human umbilical vein endothelial cells. J Biol Chem 1994; 269: 13936-13941
25. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65: 55-63
26. Fourrier F, Chopin C, Huart JJ, Runge I, Caron C, Goudemand J. Double-blind, placebo-controlled trial of antithrombin III concentrates in septic shock with disseminated intravascular coagulation. Chest 1993; 104: 882-888
27. Inthorn D, Hoffmann JN, Hartl WH, Muhlbayer D, Jochum M. Antithrombin III supplementation in severe sepsis: beneficial effects on organ dysfunction. Shock 1997; 8: 328-334
28. Bucur SZ, Levy JH, Despotis GJ, Spiess BD, Hillyer CD. Uses of antithrombin III concentrate in congenital and acquired deficiency states. Transfusion 1998; 38: 481-498